Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Follow the firms, the rounds and the people behind them.
Firms, funds, rounds and the people behind them, read from filings and announcements. Free to read, with the source and the date on every row.
What are you trying to do?
Who is funding what, who co-invests with whom, and which firms are active right now.
- Firms and funds
- Co-investor pairs
- Rounds on the record
The firms that actually write cheques at your stage, and the partners who lead them.
- Partners who lead rounds
- The firm behind each one
- What they have already funded
Fund filings, limited partners on the record and what peers of your size have closed.
- Funds and filings
- Limited partners
- Peer closings
Or keep reading. Everything below is public, and picking a door only changes what leads.
Search by what an investor has done, not what its website says
Every organization here entered through a public record: a Form ADV filing that claims the venture capital fund adviser exemption or reports venture funds, a Form D venture vehicle, a portfolio page, or a cited announcement. The class chip says what kind of organization it is and how sure we are; the profile says why. Candidates are shown as candidates and are not counted as coverage.
A privately owned wealth advisory and multi-family office serving families, business owners and entrepreneurs since 2000, with offices in Dallas, Fort Worth, Kerrville/Austin and Danville, CA.
venture manager, reported GAV $12.9M across 2 vehicles
registered adviser; venture funds are 0% of 1 private funds
Leveraging CoveMark’s partnerships with leading industry experts, we provide our investors access to exclusive investment opportunities working with quality operators that have proven track records.
Berch Capital. Simplifying access to private markets, without simplifying the work.
Montrose Lane is the leading venture capital GP-led secondaries investor, delivering institutional-grade creative liquidity solutions to the venture secondary market.
registered adviser; venture funds are 0% of 1 private funds
Banner VC backs the founders building the next generation of American innovation.
venture manager, reported GAV $37.2M across 6 vehicles
corporate parent: BFW Company
Discover Brigham Exploration, a premier non-operated oil and gas acquisition and management company focused on assets in the Permian Basin of Texas and New Mexico. Our mission is to provide access to affordable energy, which enhances our society , the environment, and overall human flourishing.
venture manager, reported GAV $16.1M across 8 vehicles
The road ahead is inherently individual. Three Bell Capital protects your family, your interests, and your choices as your path ahead develops.
seed vehicles only
venture manager, reported GAV $55M across 3 vehicles
First Bight is North America
Gore Range Capital is a venture capital firm focused on hands-on investing in early-stage healthcare businesses where it can offer not just capital but insights
Ecliptic Capital - Invest in Innovation
One firm, 2 filing advisers on t••••••••• · T••••••• T•••••••••
venture manager, reported GAV $28.1M across 3 vehicles
registered adviser; venture funds are 0% of 1 private funds
venture manager, reported GAV $35.0M across 6 vehicles
venture manager, reported GAV $94M across 1 vehicles
no sworn venture fact yet (name or round mention only)
venture manager, reported GAV $85M across 1 vehicles
Venture Capital focused on digital disruption. Home bases in the Nordic countries and Silicon Valley. Investing in disruptive and scalable Nordic companies.
venture manager, reported GAV $41.4M across 3 vehicles
seed vehicles only
venture manager, reported GAV $16.4M across 4 vehicles
One firm, 2 filing advisers on f••••••••• · F•••• P•••••••
Identify, Develop, Empower Leaders
name or self-description says seed
no sworn venture fact yet (name or round mention only)
STELLAR is a growth equity firm investing in late-stage private companies and connecting innovative companies with value-add investors.
venture manager, reported GAV $48.5M across 1 vehicles
venture manager, reported GAV $12.4M across 1 vehicles
Investing in America’s wildest dreams at Pre-Seed and Seed
Empower your financial future with Concorde Investment Management in Dallas, TX. Specializing in wealth management and preservation, we offer personalized advisory services, strategic portfolio planning, and exclusive private capital investments. Backed by 45 years of integrity, experience, and research-driven strategies to grow and safeguard your legacy.
registered adviser; venture funds are 22% of 9 private funds
Woods Capital is an integrated real estate company focused on the U.S. real estate market.
registered adviser; venture funds are 20% of 13 private funds
One firm, 2 filing advisers on s••••••••• · S••••• C•••• V•••••••
Silver Creek Ventures is a Venture Capital firm focused on IT opportunities in Texas and California
venture manager, reported GAV $28.2M across 1 vehicles
corporate parent: CR Financial Holdings, Inc.
venture manager, reported GAV $22.1M across 1 vehicles
venture manager, reported GAV $27.6M across 2 vehicles
About SALI Founded in 2002, SALI Fund Services, a JTC Group company, provides a turn-key solution for the creation and administration of Insurance Dedicated Funds (IDFs). Currently, SALI administers 200+ IDFs for a broad range of asset managers, from boutique hedge funds to the largest wealth management institutions in the world. SALI enables investment managers to create […]
A co-investment group for accredited investors. Invest deal by deal in acquisitions of established lower middle market companies. Apply for access.
venture manager, reported GAV $3.5M across 5 vehicles
The World Deserves Craft. Brad (at) thirdcraft.com
Curative Ventures is a capital and talent partner to category-defining biotech companies that are developing new therapies to dramatically improve patient outcomes.
Early-stage medical and health technology investing
The rest of the firm names are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
The record above stays free. What you pay for is the depth behind it.
Free to read. $199 a month to work in.
The full comparisonNo account. What a visitor and a search engine both see.
- Every entity by name, with its type and its record
- The dated public tape: what changed and when
- The source and the date on every published row
- The methodology, in full
Enough to be useful on its own, and it is how we learn what you came for.
- Follow entities and get a weekly digest of what moved
- Save searches and keep one universe
- A small monthly reveal allowance, to see what a contact looks like
- A small export, with its source column
or 10 months paid yearly. The working tier: the depth and the reach behind every lock on this vertical.
- Reveal the published contact line, with its source
- The whole change history on any record, back to first seen
- Every filter, across the whole record rather than the first page
- CSV export with the source column intact
- 250 follows, 25 saved screens, 5 universes
For the people who work this market every day rather than look things up in it.
- Alerts the day something moves, on an entity, a screen or a universe
- Continuous monitoring with a daily digest
- Exports at the size you actually load into a CRM
- A reveal allowance for a working desk, not a sample
- 2,000 follows, 100 saved screens, 25 universes
All nine verticals, and the joins between them. The one thing here that no list you can buy anywhere else contains.
- Every vertical, at Pro depth
- The same entity across all nine graphs, joined on identity
- Cross-graph search, universes and alerts
- One invoice instead of a collection of subscriptions
The family offices behind the LP line in these funds.
$249 / month
Where these companies go after venture.
$249 / month
The institutions that commit to funds at this stage.
$299 / month
Each is its own subscription. Three or more and the whole Factory costs less, at $599 a month for all nine.
Every row on this page carries its source and its date. The methodology says what is measured, what is inferred, and what DFX does not claim. The Data Factory is this and eight other graphs, joined.